Dr. Mitul B. Kadakia, MD

Dr. Kadakia practices at Alta Bates Summit Medical Center in Oakland, California, part of Sutter Health.

Dr. Kadakia's NPI, 1417157652, was assigned on July 24, 2007. Dr. Kadakia graduated from Harvard Medical School in 2007. Dr. Kadakia's California license number on file is A130262.

Dr. Kadakia's primary practice is Alta Bates Summit Medical Center, at 350 Hawthorne Avenue, Oakland, CA 94609 in Alameda County. The practice phone is (510) 655-4000.

Dr. Kadakia's primary practice is Alta Bates Summit Medical Center in Oakland, California, part of Sutter Health. Dr. Kadakia is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Kadakia to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kadakia practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Kadakia's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Kadakia is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Kadakia's licenses on file in 3 states: California, Pennsylvania and Massachusetts.

Dmand AI lists angioplasty and cardiac catheterization among the conditions Dr. Kadakia treats.

CMS data shows 3,467 Medicare services from Dr. Kadakia across 27 procedure codes in 2024, for 1,461 Medicare patients. Medicare paid $306,707 for them.

CMS counts 1,461 Medicare patients who saw Dr. Kadakia in 2024. The largest group is 75 to 84, with 601 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kadakia's median patient age at 70, with 42% women.

In 2024, Dr. Kadakia wrote 2,104 Medicare Part D claims for 353 patients. 79% of them were for generic drugs. CMS names the drug for 1,942 of them, across 31 drugs with 11 or more claims each, at $469,730 in total drug cost. In 2023, CMS named 1,857 claims across 26 drugs.

Dr. Kadakia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kadakia as offering telehealth. CMS counts 29 procedures of coronary angioplasty and stenting by Dr. Kadakia, more than 64% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Kadakia, published from 2011 to 2020. 2014 was the busiest year, with 3. The most frequent topics are Femoral Artery, Aortic Valve and Cardiac Catheterization. Dr. Kadakia has published most often in Catheter Cardiovasc Interv. Dr. Kadakia's most frequent co-authors are Saif Anwaruddin, MD, Joseph E. Bavaria, MD and Antonious S. Attallah, MD.

CMS Open Payments shows 252 general payments to Dr. Kadakia from 18 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 53% of the total. Edwards Lifesciences Corporation paid the most, $15,131.

Dmand AI lists 2 awards for Dr. Kadakia, most recently Gregory Braden Memorial Fellow of the Year in 2014.

Dr. Kadakia graduated from Harvard Medical School in 2007. Dr. Kadakia is a member of ACC, AHA and Society of Cardiovascular Angiography and Interventions.

Dr. Kadakia is in network with 14 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.